Carvykti carries a boxed warning for potential side effects, including cytokine release syndrome, immune effector cellassociated neurotoxicity syndrome and secondary malignancies
A 2026 UK evidence review of postural orthostatic tachycardia syndrome cognitive dysfunction, cerebral blood flow, the 2025 Adelaide SPECT study, the 14-fold Read the full review Tick-Borne Disease & Neuroinflammation 3 June 2026 Dihexa for Lyme Disease Brain Fog, Neuroborreliosis & PTLDS: The 2026 UK Review Can Dihexa help Lyme disease brain fog or Post-Treatment Lyme Disease Syndrome (PTLDS)
NAD+ Patches / Injections Discover NAD+ Patches and Injections at InjectAbility Clinic
The FDA has issued safety communications regarding compounded GLP-1 receptor agonists, including tirzepatide and semaglutide, warning about adverse events from bacterial contamination, incorrect dosing, and use of improper ingredients
Their incorporation into liposomes allows cyclic dosage, tunable release of both hydrophilic and hydrophobic drugs, and controlled release of therapeutic agents over extended periods